Antitumor efficacy of the novel RAF inhibitor GDC-0879 is predicted by BRAFV600E mutational status and sustained extracellular signal-regulated kinase/mitogen-activated protein kinase pathway suppression. (Q39874679)
scientific article published on 10 March 2009
Language:
(P31) (Q13442814)
(P50) (Q47824600)
(Q30582818)
(P304) 3042-3051
(P407) (Q1860)
(P433) 7
(P478) 69
(P577) Tuesday, March 10, 2009
(P921) (Q27077781)
(P1433) (Q326097)
(P1476) "Antitumor efficacy of the novel RAF inhibitor GDC-0879 is predicted by BRAFV600E mutational status and sustained extracellular signal-regulated kinase/mitogen-activated protein kinase pathway suppression" (language: en)
(P2093) Klaus P Hoeflich
Sylvia Herter
Janet Tien
Leo Wong
Leanne Berry
Jocelyn Chan
Carol O'Brien
Somasekar Seshagiri
Howard Stern
Edna Choo
Lesley Murray
Lori S Friedman
Marcia Belvin
(P2860) (Q28145747)
(Q27860760)
other details
description scientific article published on 10 March 2009

External Links